Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment.

Henriquez-Figuereo, Andreina; Moreno, Esther; Sanmartin, Carmen; Plano, Daniel

Henriquez-Figuereo, Andreina; Moreno, Esther; Sanmartin, Carmen; Plano, Daniel.

Afiliação

Henriquez-Figuereo A; Department of Pharmaceutical Technology and Chemistry, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.
Moreno E; Institute of Tropical Health (ISTUN), University of Navarra, 31008 Pamplona, Spain.
Sanmartin C; Department of Pharmaceutical Technology and Chemistry, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.
Plano D; Institute of Tropical Health (ISTUN), University of Navarra, 31008 Pamplona, Spain.

Molecules ; 28(15)2023 Aug 03.

Article em En | MEDLINE | ID: mdl-37570815

Assuntos

Antiprotozoários; Leishmania infantum; Leishmaniose Visceral; Humanos; Animais; Camundongos; Leishmaniose Visceral/tratamento farmacológico; Antiprotozoários/uso terapêutico; Anfotericina B/farmacologia; Anfotericina B/uso terapêutico; Paromomicina/farmacologia; Combinação de Medicamentos; Camundongos Endogâmicos BALB C

Palavras-chave

Leishmania; drug-combination; selanyl; selenium; synergy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leishmania infantum / Leishmaniose Visceral / Antiprotozoários Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google